Clinical Data Studio has supported 465 global studies since its launch in 2024, reducing data review cycles by up to 80% and ...

Centene withdrew its previous 2025 earnings guidance and all underlying guidance elements based on the company's preliminary ...

The transition from writing to programming regulatory submissions represents one of the most significant efficiency ...

Retail chatter around Sunshine Biopharma surged late Wednesday after the company introduced Niopeg, its first biosimilar drug ...

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; 'Cyclacel” or the 'Company”), a biopharmaceutical company ...

Galena Biopharma (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Vor Biopharma gains rights to autoimmune drug telitacicept, raises capital and names a new CEO in a major strategic reset.

The first pillar focuses on enhancing the value chain. “Ireland is well-positioned to become a key orchestrator within the ...

Investing.com -- Vor Biopharma Inc (NASDAQ: VOR) stock surged 85% after the company announced an exclusive licensing agreement with China’s RemeGen Co., Ltd. for telitacicept, a novel dual-target ...

For reference, Novo Nordisk also offers a highly successful weight loss drug, Wegovy, a GLP-1 receptor agonist.

Many leading growth stocks in the U.S. market are found in this sector, due to the significant rallies that biopharmaceutical companies experience when a key positive trial result is announced or ...

Arsenale Bioyards recognized the inefficiencies and developed a platform that could radically change biomanufacturing, much like the Bessemer converter in the mid-19th century transformed the steel ...